chr16-1220162-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021098.3(CACNA1H):​c.6230G>A​(p.Arg2077His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.608 in 1,523,120 control chromosomes in the GnomAD database, including 285,545 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 32651 hom., cov: 35)
Exomes 𝑓: 0.60 ( 252894 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.784
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.9449054E-7).
BP6
Variant 16-1220162-G-A is Benign according to our data. Variant chr16-1220162-G-A is described in ClinVar as [Benign]. Clinvar id is 96016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1220162-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.855 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1HNM_021098.3 linkuse as main transcriptc.6230G>A p.Arg2077His missense_variant 35/35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkuse as main transcriptc.6230G>A p.Arg2077His missense_variant 35/351 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000565831.6 linkuse as main transcriptc.6212G>A p.Arg2071His missense_variant 33/331 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkuse as main transcriptc.6191G>A p.Arg2064His missense_variant 35/355 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000569107.5 linkuse as main transcriptc.2468G>A p.Arg823His missense_variant 17/171 ENSP00000454990.2 H3BNT0
CACNA1HENST00000564231.5 linkuse as main transcriptc.2420G>A p.Arg807His missense_variant 18/181 ENSP00000457555.2 H3BUA8
CACNA1HENST00000562079.5 linkuse as main transcriptc.2402G>A p.Arg801His missense_variant 17/171 ENSP00000454581.2 H3BMW6
CACNA1HENST00000639478.1 linkuse as main transcriptn.*1278G>A non_coding_transcript_exon_variant 35/355 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkuse as main transcriptn.*4048G>A non_coding_transcript_exon_variant 35/355 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000639478.1 linkuse as main transcriptn.*1278G>A 3_prime_UTR_variant 35/355 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkuse as main transcriptn.*4048G>A 3_prime_UTR_variant 35/355 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.650
AC:
98790
AN:
152052
Hom.:
32623
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.700
Gnomad AMI
AF:
0.573
Gnomad AMR
AF:
0.702
Gnomad ASJ
AF:
0.711
Gnomad EAS
AF:
0.876
Gnomad SAS
AF:
0.559
Gnomad FIN
AF:
0.710
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.585
Gnomad OTH
AF:
0.655
GnomAD3 exomes
AF:
0.657
AC:
109910
AN:
167372
Hom.:
36649
AF XY:
0.646
AC XY:
59692
AN XY:
92374
show subpopulations
Gnomad AFR exome
AF:
0.705
Gnomad AMR exome
AF:
0.747
Gnomad ASJ exome
AF:
0.709
Gnomad EAS exome
AF:
0.895
Gnomad SAS exome
AF:
0.568
Gnomad FIN exome
AF:
0.701
Gnomad NFE exome
AF:
0.595
Gnomad OTH exome
AF:
0.646
GnomAD4 exome
AF:
0.604
AC:
827558
AN:
1370950
Hom.:
252894
Cov.:
70
AF XY:
0.602
AC XY:
405972
AN XY:
674462
show subpopulations
Gnomad4 AFR exome
AF:
0.709
Gnomad4 AMR exome
AF:
0.735
Gnomad4 ASJ exome
AF:
0.697
Gnomad4 EAS exome
AF:
0.901
Gnomad4 SAS exome
AF:
0.561
Gnomad4 FIN exome
AF:
0.690
Gnomad4 NFE exome
AF:
0.582
Gnomad4 OTH exome
AF:
0.625
GnomAD4 genome
AF:
0.650
AC:
98862
AN:
152170
Hom.:
32651
Cov.:
35
AF XY:
0.657
AC XY:
48845
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.699
Gnomad4 AMR
AF:
0.703
Gnomad4 ASJ
AF:
0.711
Gnomad4 EAS
AF:
0.876
Gnomad4 SAS
AF:
0.559
Gnomad4 FIN
AF:
0.710
Gnomad4 NFE
AF:
0.585
Gnomad4 OTH
AF:
0.660
Alfa
AF:
0.607
Hom.:
47863
Bravo
AF:
0.659
TwinsUK
AF:
0.570
AC:
2113
ALSPAC
AF:
0.589
AC:
2269
ESP6500AA
AF:
0.728
AC:
2894
ESP6500EA
AF:
0.608
AC:
5031
ExAC
AF:
0.627
AC:
73990
Asia WGS
AF:
0.720
AC:
2501
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 20, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 27, 2019- -
Epilepsy, childhood absence, susceptibility to, 6 Benign:2
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtJul 28, 2017- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 03, 2013- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
0.74
DANN
Uncertain
0.99
DEOGEN2
Benign
0.086
T;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.60
T;T;T;.
MetaRNN
Benign
8.9e-7
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.11
N;.;.;.
PrimateAI
Benign
0.41
T
PROVEAN
Benign
0.45
N;.;N;N
REVEL
Benign
0.033
Sift
Benign
0.59
T;.;T;T
Sift4G
Benign
0.59
T;.;T;T
Polyphen
0.0
B;.;B;B
Vest4
0.033
ClinPred
0.0018
T
GERP RS
0.76
Varity_R
0.022
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1054645; hg19: chr16-1270162; COSMIC: COSV52354598; COSMIC: COSV52354598; API